Literature DB >> 18093583

Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury.

Hui Chen1, Bianzhi Xing, Xiuheng Liu, Bingyan Zhan, Jiangqiao Zhou, Hengcheng Zhu, Zhiyuan Chen.   

Abstract

Ischemia/reperfusion injury, which is commonly seen in the field of renal surgery or transplantation, is a major cause of acute renal failure. Previous studies showed that ozone oxidative preconditioning (OzoneOP) attenuated renal ischemia/reperfusion injury. The objective of this study was to examine the role of the OzoneOP in modulating inflammation and apoptosis after renal ischemia/reperfusion injury. Rats were subjected to 45 min of renal ischemia, with or without treatment with OzoneOP (1 mg/kg). Renal function, inflammation and apoptosis were compared at 24 h after renal injury. OzoneOP improved the renal dysfunction and reduced inflammation and apoptosis after ischemia/reperfusion injury. In conclusion, OzoneOP has potent anti-apoptotic and anti-inflammatory properties. These findings may have major implications in the treatment of human ischemic acute renal failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093583     DOI: 10.1016/j.ejphar.2007.11.050

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  The effects of ozone therapy and coenzyme Q₁₀ combination on oxidative stress markers in healthy subjects.

Authors:  M Inal; A Dokumacioglu; E Özcelik; O Ucar
Journal:  Ir J Med Sci       Date:  2011-01-22       Impact factor: 1.568

2.  Cerebrovascular pattern improved by ozone autohemotherapy: an entropy-based study on multiple sclerosis patients.

Authors:  Filippo Molinari; Daniele Rimini; William Liboni; U Rajendra Acharya; Marianno Franzini; Sergio Pandolfi; Giovanni Ricevuti; Francesco Vaiano; Luigi Valdenassi; Vincenzo Simonetti
Journal:  Med Biol Eng Comput       Date:  2016-10-12       Impact factor: 2.602

3.  Ischemic postconditioning attenuates inflammation in rats following renal ischemia and reperfusion injury.

Authors:  Hui Chen; Lei Wang; Bian-Zhi Xing; Xiu-Heng Liu; Zhi-Yuan Chen; Xiao-Dong Weng; Tao Qiu; Lin Liu
Journal:  Exp Ther Med       Date:  2015-05-22       Impact factor: 2.447

4.  Mitochondria as the memory of preconditioning.

Authors:  Sarah Zerimech; Hung Nguyen; Selva Baltan
Journal:  Cond Med       Date:  2021-08-21

5.  Sinomenine protects mice against ischemia reperfusion induced renal injury by attenuating inflammatory response and tubular cell apoptosis.

Authors:  Zhiqing Zhao; Rui Guan; Shaohua Song; Mingjian Zhang; Fang Liu; Meng Guo; Wenyuan Guo; Qilin Yu; Luding Zhang; Quanxing Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

6.  Major Ozonated Autohemotherapy Preconditioning Ameliorates Kidney Ischemia-Reperfusion Injury.

Authors:  Eyup Burak Sancak; Hakan Turkön; Selma Çukur; Sevilay Erimsah; Alpaslan Akbas; Murat Tolga Gulpinar; Huseyin Toman; Hasan Sahin; Metehan Uzun
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

7.  Enhanced Hsp70 expression protects against acute lung injury by modulating apoptotic pathways.

Authors:  Gabriella Aschkenasy; Zohar Bromberg; Nichelle Raj; Clifford S Deutschman; Yoram G Weiss
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

8.  Ozone oxidative preconditioning inhibits renal fibrosis induced by ischemia and reperfusion injury in rats.

Authors:  Lei Wang; Hui Chen; Xiu-Heng Liu; Zhi-Yuan Chen; Xiao-Dong Weng; Tao Qiu; Lin Liu; Heng-Cheng Zhu
Journal:  Exp Ther Med       Date:  2014-10-06       Impact factor: 2.447

9.  Therapeutic antioxidant medical gas.

Authors:  Atsunori Nakao; Ryujiro Sugimoto; Timothy R Billiar; Kenneth R McCurry
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

10.  Methane-rich saline attenuates ischemia/reperfusion injury of abdominal skin flaps in rats via regulating apoptosis level.

Authors:  Kexin Song; Mingzi Zhang; Jianqiang Hu; Yunqi Liu; Yifang Liu; Youbin Wang; Xuemei Ma
Journal:  BMC Surg       Date:  2015-07-31       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.